MultiVitamine Minerale fara Fier cu Potenta inalta + B Complex + Lecitina

Multivitamine cu Fier favorizeza scurtarea de telomere si accelerarea imbatranirii

Vitamine cu calitate USP

1. MultiVitamine au efect de prelungirea telomerelor la femei cu 5.1% - Telomere este un marker a varstei biologice

2. Lungimea de Telomere este un indicator a varstei biologice

Background: Telomere length may be a marker of biological aging. Multivitamin supplements represent a major source of micronutrients, which may affect telomere length by modulating oxidative stress and chronic inflammation.

Results: Compared with nonusers, the relative telomere length of leukocyte DNA was on average 5.1% longer among daily multivitamin users (P for trend = 0.002). In the analysis of micronutrients, higher intakes of vitamins C and E from foods were each associated with longer telomeres, even after adjustment for multivitamin use.

Conclusion: This study provides the first epidemiologic evidence that multivitamin use is associated with longer telomere length among women.

Concluzie: Evidenta ca folosirea de MultiVitamine este asociat cu prelungirea de telomere la femei cu 5.1% - Telomere este un marker a varstei biologice

Telomere se scurteza cu diviziunea celulara

- Multivitamine cu Fier favorizeza scurtarea de telomere (Iron supplements with shorter telomeres) - Terapia prin chelare la supraincarcarea cu Fier care induce Alzheimer si Parkinson

- Multivitamine cu Fier favorizeza scurtarea de telomere si accelerarea imbatranirii

- Se recomanda: MultiVitamine fara continutul de Fier (Iron-Free Multivitamins)

http://www.lef.org/newsletter/2009/0317_Longer-Telomeres-Associated-with-Multivitamin-Use.htm

- Telomerele sint vulnerabile la stresul oxidativ, inflamatiile induc stresul oxidativ si activitate scazuta de telomeraza enzima care este responsabila pentru mentinerea lungimii telomerelor

- Folosirea de Antioxidanti, Vitamina B complex si minerale specifice care sint necesare pentru mentinerea lungimii de telomere in fapt Vitamina C si Vitamina E sa aratat creste viata celulara - Longevitate

3. Concentratia serica inalta de Vitamina D este asociat cu prelungirea de telomere la femei

Concentratia serica inalta de Vitamina D este asociat cu prelungirea de telomere la femei

4 Multivitamine Minerale este un complet multi vitamin mineral cu oligoelemente necesare la copii.

5 Multivitamine Minerale ofera un spectru larg de multi vitamine minerale, oligoelemente cu mare capacitate de absorbtie intareste sistemul imunitar si previne infectiile la persoanele in virsta

6 Multivitamine Minerale ajuta la pastrarea sanatatii optimale are activitate antioxidanta de neutralizare la radicalii liberi prin antioxidantii Vitamina C si Vitamina E

Miracolul antioxidant	Terapia Anti-Aging cu antioxidanti
	Fountain of Youth Anti-Aging Antioxidant, Antioxidanti, Antioxidantii fantana tineretii

7 Vitamina A si Beta-Caroten o hrana optimala, mareste acuitatea vizuala

Control Oftamologic	Vitamina A si Beta-Caroten pentru o vedere oculara mai buna

8 Vitamina A si Vitamina E ca supliment nutritiv in retinita pigmentara, studiu randomizat, dublu-orb, placebo controlat.

9 Vitamina C si Vitamina E previne cataracta un rezultat al procesului de inbatrinire.

10 Biotina suplimente nutritive pentru par, piele, raspunde la intarirea de unghii fragile

Caderea parului (alopecia areata)	Set Cura Alopecie-Fem cu: Extract dinSamburi de Struguri 125 mg + PABA 500 mg + Biotina 10 mg

11 Biotina si Crom picolinat inbunatateste metabolismul de glucoza la obezi cu diabet zaharat tip 2

12 Biotina o nutritie moderna pentru mentinerea sanatatii si prevenirea bolilor

13 Biotina la tratamentul de intarire a unghiilor fragile

Unghie sanatoasa, unghie fragila

14 Prevenirea de tub neural prin suplemente nitritive de Acid folic

15 Acid folic, Vitamina B12, Vitamina B6 previne bolile neuropsihiatrice

16 Rolul si functia de Vitamina B12 si Acid folic in sistemul nervos central la oamenii in virsta

17 Vitamina B1 (Tiamina), Vitamina B2 si Vitamina B6 ca antidepresiv in tratamentul geriatric de depresie cu disfunctie cognitiva

18 Vitamina B1 (Tiamina), Vitamina B2 (Riboflavina), Niacina (Vitamina B3), Vitamina B6 (Piridoxina), Biotina si Vitamina B5 (Acid Pantotenic) o hrana optimala

19 Niacina (Vitamina B3) reface activitatea cognitiva la bola Alzheimer

MultiVitamine Minerale+Lecitina in cura cu suplimente nutritive produse-naturale

20 Vitamina B6 (Piridoxina) indicat la ameteli si stari de voma la femeile gravide, studiu randomizat, dublu-orb, placebo controlat.

21 Vitamina B5 (Acid Pantotenic) si Vitamina C indicat pentru piele si vindecarea ranilor, studiu randomizat, dublu-orb, placebo controlat.

22 Vitamin C si Zinc este cel mai bun raspuns la raceala previne gripa si infectiile respiratorii

23 Vitaminei C ca antioxidant reduce colesterolul foarte important in bolile cardiovasculare

24 Vitaminei C, Vitamina E, Beta Caroten inhiba oxidatia lipoproteinelor cu densitate mica LDL - colesterol si ateroscleroza

25 Suplimente cu Vitamina D3 si Calciu la incidenta de fracturi persoanelor in virsta, studiu randomizat dublu orb placebo controlat

26 Vitamina D3, Calciu si Vitamina K previne fracturile la persoanele in virsta

Structura normala de masa osoasa	Osteoporoza	La osteoporoza se subtiaza structura masei osoase

27 Vitamina D3, Calciu, Magneziu si Vitamina K indicat pentru preventia osteoporozei

Fractura de femur la osteoporoza

28 Vitamina D si Calciu cu efect biochimic la persoanele in virsta deficiente de Vitamina D care lucrează in institutiile publice

29 Calciu si Vitamina D pentru densitatea minerala osoasa necesita femeile in virsta, recomandat este 600-800 UI

Importanta vitaminei D si a calciului la osteoporoza

30 Vitamina D3 reduce progresia de osteoartrita studiu randomizat

31 Vitamina E si Beta Caroten indicat in preinfarct miocardic

32 Vitamina C si Vitamina E cu efect la infarctul miocardic acut

33. Vitamina E si Ulei de Peste Omega-3 acizi grasi polinesaturati dupã infarctul miocardic

34 Vitamina E antioxidant in tratamentul pentru prevenirea bolilor cardiovasculare, meta analiza si studiu randomizat, dublu-orb, placebo controlat.

35. Vitamina E la pacienti cu boli coronariene, studiu randomizat, dublu-orb, placebo controlat.

36 Vitamina E si Vitamina K reduce agregarea plachetara in bolile cardiovasculare

37 Efectul Vitamina E si Beta Caroten in simptomele de progresie si diagnoza a anginei pectorale

38 Vitamina E plus Vitamina E pentru o sanatate optimala reviu critic si constructiv la bolile cardiovasculare si cancer

39 Folosirea de multi vitamine minerale la cancerul de colon

40 Vitamina E reducere incidentele de cancer de prostata

Minerale

41 Calciu activeaza energia corporala reduce greutatea corporala

42. Calciu regleaza adipozitatea, mecanism si implicatii

43 Calciu cu biodisponibilitate buna si pret de cost efectiv

Recomandarea zilnica de Calciu	Necesarul de Calciu
	1 - 3 ani 500 mg 4 - 8 ani 800 mg 9 - 18 ani 1300 mg 19 - 50 ani 1000 mg 51 + ani 1200 mg

44 Crom picolinat ca supliment nutritiv care reduce greutatea corporala studiu randomizat, dublu-orb, placebo controlat

45 Cupru indicat la ateroscleroza si bolile cardiovasculare

46. Boli cardiovasculare datorita deficientei de Cupru

47 Fier si Vitamina A indicat pentru anemie, la femei gravide

48 Rolul de Magneziu in patogeneza si tratamentul de migrena

49. Magneziu in profilaxia de migrena, studiu multi centru placebo controlat

50 Magneziu inhiba agregarea plachetara dependent de tromboza la pacienti cu boli coronariene

51 Mangan cu eficienta la osteoartrita impreuna cu Glucozamina si Condroitin sulfat

52 Deficienta de Molibden afecteaza: Moco-dependent de enzima xantin dehidrogenaza, sulfit oxidaza si aldehid oxidaza, cauza a multor boli

53 Riscul de deficienta de Iod la hrana vegetariana

54 Consecintele lipsei de Seleniu si Fier asupra metamolizmul iodului cu repercursiune la glanda tiroida

55 Seleniu previne cancerul de piele, studiu randomizat, dublu-orb, placebo controlat

56 Vitamina C si Seleniu previne cancerul

57 Ghid nutritional la suplimente nutritive cu multi vitamine

58. Acid Paraaminobenzoic PABA face parte din gruba B Complex cu efect clinic pentru ingrijirea pielii la pigmentatie si fertilitate

59 Stiinta ingrijirii parului: Terapia cu Acid Paraaminobenzoic PABA inchide culoarea firului de par alb.

60. Acid Paraaminobenzoic PABA si Acidul Pantotenic din gruba B Complex inchide culoarea firului de par alb la barbati

61 Lumina solara aduce daune pielii

62 Factorul de protectie solara SPF (Sunscreen Protection Factor) previne foto carcinogeneza indusa de razele ultraviolete tip A si B

63 Acid Paraaminobenzoic PABA la protectia tenului de razele ultraviolete care induc tumora de piele si keratoza actinica

Produse-naturale ca: Acid Paraaminobenzoic PABA pentru ingrijirea pielii

64 Acid Paraaminobenzoic PABA cu efect la factorul de protectia solara SPF (Sunscreen Protection Factor), impotriva ultravioletelor tip A si B

65. Inositol un stimulator cerebral prin cresterea nivelului in cerebral

66. Inositol (myo-Inositol) cu efect in distrofia neuroaxonala a nervului mesenteric la diabetici

67. Inositol (myo-Inositol) creste concentratia la plasma de eritrocite si tesutul muscular la persoane sanatoase sau cu diabet, la functia nervului periferic in neuropatia diabetica

68. Inositol (myo-Inositol) la functia nervului periferic in neuropatia diabetica

69. Inositol (myo-Inositol) la functia nervului periferic la diabet

70. Inositol (myo-Inositol) in terapia de hiperglicemie, care induce embriopatii, Inositol ca profilaxie la malformatiile congenitale

Inositol tine glicemia sub control in terapia de hiperglicemie

Celule cu rezistenta insulinica

71. Inositol (myo-Inositol) si neural tube defect la urmasii cu diabet

72. Inositol (myo-Inositol) la bulimie si imbuibare

73. Inositol (myo-Inositol) in tratamentul de depresie, studiu randomizat dublu orb placebo controlat

74. Inositol (myo-Inositol) in tratamentul de depresia bipolara

75. Inositol (myo-Inositol) cu relaxare psihica in tratamentul simptomelor psihiatrice

76. Colina Bitartrat un precursor in sinteza de Acetilcolina un neurotransmitator important

Colina Bitartrat un stimulator cerebral

77. Colina indicat la terapia cognitiva si dementa

78. Deficitul de Colina la boala Alzheimer

79. Colina Colina si Lecitina in sanatatea si boala umana.

80. Lecitina imbunatateste memoria adultilor, creste capacitatea de memorare

81. Fosfatidilcolina din Lecitina indicat ca cura de memorie pentru dementa sau declin cognitiv

82. Lecitina sau Colina in tratamentul bolilor neorologice ca Alzheimer si Parkinson

83. Lecitina la boala Alzheimer, studiu randomizat, dublu-orb, placebo controlat

Creier sanatos	Creier cu Alzheimer

84. Lecitina in tratamentul de scurta si lunga durata la boala Alzheimer studiu randomizat, dublu-orb, placebo controlat

85. Lecitina cu functie in invatare si exercitiu de memorare la boala suspect de Alzheimer

86. Lecitina si Colina cu inalta doza la pacienti cu boala Alzheimer

87. Lecitina in tratamentul de reducere a nivelului seric al colesterolului total in hipercolesterolemie

88. Lecitina are efect de a reduce valorile lipoproteinelor cu densitate joasa (colesterolul-LDL)

89. Lecitina creste concentratia plasmatica de colina si reduce steatoza hepatica

90. Lecitina si Colina in mentinerea sanatatii umane si prevenirea bolilor

91. Lecitina cu avantaj in bolile cronice de ficat

Studiu pe o perioada de 50 de ani

Cultura intensiva	Ingrasamintele chimice, ierbicide,	combaterea daunatorilor,
	sint cauze ca: Fructele si zarzavaturile scad din calitate tot mai mult.

- Studiu pe o perioada de 10 ani

Trebuie sa ajutam organizmul printr-o varietate alimentara, prin sprijinirea alimentatiei cu suplimente nutritive si antioxidante protectoare.

Bibliografie-Referinte: MultiVitamine

Informatii din bibliografia electronica la tema: Nutritie si sanatate

1. Xu Q, Parks CG, Deroo LA, Cawthon RM, Sandler DP, Chen H. Multivitamin use and telomere length in women. Am J Clin Nutr. 2009 Mar 11
2 Benetos A, Okuda K, Lajemi M, Kimura M, Thomas F, Skurnick J, Labat C, Bean K, Aviv A. Telomere length as an indicator of biological aging: The gender effect and relation with pulse pressure and pulse wave velocity. Center "Investigations Preventives et Cliniques" (IPC), INSERM U337, Paris, France. Hypertension. 2001 Feb;37(2):381-5.
3. Richards JB, Valdes AM, Gardner JP, Paximadas D, Kimura M, Nessa A, Lu X, Surdulescu GL, Swaminathan R, Spector TD, Aviv A. Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women. Twin Research and Genetic Epidemiology, St Thomas' Hospital, King's College, London School of Medicine, London, United Kingdom. Am J Clin Nutr. 2007 Nov;86(5):1420-5.
4. Berdanier, C. Advanced Nutrition: Micronutrients. CRC Press, 1998.
- American Academy of Pediatrics Committee on Nutrition. Vitamin and mineral supplement needs of normal children in the United States. Pediatrics 66:1015-1020, 1980.
5 Chandra K. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. The Lancet 1992 Nov 7;340(8828):1124-7.
6 Hercberg S. Antioxidant micronutrients and chronic degenerative pathology: the role of complementary nutritional doses. Bull Mem Acad R Med Belg 1997;152(10-11):379-85; discussion 385-7.
- Packer, L. (1995): Oxidative Stress, Antioxidants, Aging and Disease. Oxidative Stress and Aging; Birkhauser Verlag. 114.
7 Thurnham DI, Northrop-Clewes CA. Optimal nutrition: vitamin A and the carotenoids. Proc Nutr Soc. 1999;58(2):449-457.
- Wolf G. A history of vitamin A and retinoids. FASEB J. 1996; 10:1102-1107.
- Acott TS, Weleber RG. Vitamin A megatherapy for retinal abnormalities. Nature Med. 1995; 1:884-885.
- Losonczy, K.G., et al. Vitamin E and vitamin C supplement use. American Journal of Clinical Nutrition, 1996.
- Brown NA, Bron AJ, Harding JJ, Dewar HM. Nutrition supplements and the eye. Eye 1998;12 ( Pt 1):127-33.
- Jacobson SG, Cideciyan AV, Regunath G, et al. Night blindness in Sorsby's fundus dystrophy reversed by vitamin A. Nature Gen. 1995; 11:27-32.
8 Berson EL, Rosner B, Sandberg MA, et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol. 1993;111(6):761-772.
9 Robertson, J., et al. A possible role for vitamins C and E in cataract prevention. American Journal of Clinical Nutrition, 1991 supplement.
10 Albarracin CA, Fuqua BC, Evans JL, Goldfine ID. Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Alpha Therapy Center, 4626 Weber Road, Suite 100, Corpus Christi, TX 78411, USA. Diabetes Metab Res Rev. 2008 Jan-Feb;24(1):41-51.
11 Albarracin CA, Fuqua BC, Evans JL, Goldfine ID. Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Alpha Therapy Center, 4626 Weber Road, Suite 100, Corpus Christi, TX 78411, USA. Diabetes Metab Res Rev. 2008 Jan-Feb;24(1):41-51.
12 Mock DM. Biotin. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore: Lippincott Williams & Wilkins; 1999:459-466.
- Mock DM. Biotin. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ, eds. Modern Nutrition in Health and Disease. 10th ed. Baltimore: Lippincott Williams & Wilkins; 2006:482-497.
13 Floersheim GL. Treatment of brittle fingernails with biotin. Z Hautkr. 1989 Jan 15;64(1):41-8.
14 Locksmith GJ, Duff P. Preventing neural tube defects: the importance of periconceptional folic acid supplements. Obstet Gynecol 1998 Jun;91(6):1027-34.
15 Bottiglieri T. Folate, vitamin B12, and neuropsychiatric disorders. Nutr Rev. 1996; 54:382-390.
- Carmel R, Gott PS, Waters CH, et al. The frequency of low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities. Eur J Haematol. 1995; 54:245-253.
-Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med. 1988; 318:1720-1728.
- Bernstein AL. Vitamin B6 in clinical neurology. Ann NY Acad Sci. 1990; 585:250-260.
16 Weir DG, Scott JM. Brain function in the elderly: role of vitamin B12 and folate. Br Med Bull. 1999; 55:669-682.
17 Bell, I.R. et al. Vitamin B1, B2, and B6 augmentation of tricyclic antidepressant treatment in geriatric depression with cognitive dysfunction. J. Am. Coll. Nutr. 1992; 11: 159-63.
18 Bender DA. Optimum nutrition: thiamin, biotin and pantothenate. Proc Nutr Soc. 1999;58(2):427-433.
- Powers HJ. Current knowledge concerning optimum nutritional status of riboflavin, niacin and pyridoxine. Proc Nutr Soc. 1999;58(2):435-440.
19 Green KN, Steffan JS, Martinez-Coria H, Sun X, Schreiber SS, Thompson LM, LaFerla FM. Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. Department of Neurobiology and Behavior, University of California, Irvine, Irvine, California 92697-4545, USA. J Neurosci. 2008 Nov 5;28(45):11500-10.
20Vutyavanich T, Wongtra-ngan S, Ruangsri R. Pyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol. 1995;173(3 Pt 1):881-884.
21 Vaxman F, Olender S, Lambert A, et al. Effect of pantothenic acid and ascorbic acid supplementation on human skin wound healing process. A double-blind, prospective and randomized trial. Eur Surg Res. 1995;27(3):158-166.
22 Pauling L. The significance of the evidence about ascorbic acid and the common cold.Proc Natl Acad SciUSA. 1971; 68:2678-2681.
- Anon. Zinc lozenges reduce cold symptoms. Nutr Rev. 1997; 55:82-88.
23 Johnston, C.S. "Recommendations for Vitamin C Intake," JAMA, vol. 282, no. 22 (December 1999).
- Jha, P., et al., "The Antioxidant Vitamins and Cadiovascular Disease," Ann. Of Intern. Med., vol. 123 (1995), pp. 860.
- Fidanza, A. et al. Vitamin C and cholesterol. Int. J. Vit. Nutr. Res. 1982; 23:153-171.
24 Jialal, I., Fuller, C.J. Effect of vitamin E, Vitamin C and beta-carotene on LDL oxidation and atherosclerosis. Canad. J. Cardiol. 1995; 11, (Suppl G): 97-103.
- Kayden HJ, Traber M. Absorption, lipoprotein transport and regulation of plasma concentrations of vitamin E in humans. J Lipid Res. 1993; 34:343-358.
25 Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med. 1996; 124:400-406.
- Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures. N Engl J Med. 1992; 327:1637-1642.
26Lips P, Graafmans WC, Ooms ME, et al. Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med. 1996; 124:400-406.
- Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures. N Engl J Med. 1992; 327:1637-1642.
- O'Brien KO. Combined calcium and vitamin D supplementation reduces bone loss and fracture incidence in older men and women. Nutr Rev. 1998; 56(5 Pt 1):148-150.
- LeBoff MS, Kohlmeier L, Hurwitz S, et al. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA. 1999; 281:1505-1511.
- Booth SL, Tucker KL, Chen H, et al. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women.Am J Clin Nutr. 2000; 71:1201-1208.
- Sarah L. Booth3, Ligia Martini, James W. Peterson, Edward Saltzman, Gerard E. Dallal and Richard J. Wood. Dietary Phylloquinone Depletion and Repletion in Older Women. Human Nutrition and Metabolism. Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111
- Feskanich D, Weber P, Willett WC, et al. Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr. 1999; 69:74-79.
27 Fujita T. Vitamin D in the treatment of osteoporosis. Proc Soc Exp Biol Med. 1992; 199:394-399.
- Amin S, La Valley MP, Simms RW, Felson DT. The role of vitamin D in corticosteroid-induced osteoporosis. A meta-analytic approach. Arthritis Rheum. 1999; 42:1740-1751.
- Shearer MJ. The roles of vitamins D and K in bone health and osteoporosis prevention. Proc Nutr Soc. 1997;56(3):915-937.
- Olson RE. Osteoporosis and vitamin K intake (editorial). Am J Clin Nutr. 2000; 71:1031-1032.
- Vermeer C, Jie KS, Knapen MH. Role of vitamin K in bone metabolism. Annu Rev Nutr. 1995; 15:1-22.
- Heaney RP. Calcium, dairy products and osteoporosis. J Am Coll Nutr. 2000;19(2 Suppl):83S-99S.
- Sojka JE, Weaver CM. Magnesium supplementation and osteoporosis. Nutr Rev. 1995;53(3):71-74.
28 Chapuy MC, Chapuy P, Thomas JL, Hazard MC, Meunier PJ. Biochemical effects of calcium and vitamin D supplementation in elderly, institutionalized, vitamin D-deficient patients. National Institute for Health and Medical Research (INSERM) unit 403, Edouard Herriot Hospital, Lyon, France. Rev Rhum Engl Ed. 1996 Feb;63(2):135-40.
29. Dawson-Hughes B. Calcium and vitamin D nutritional needs of elderly women. Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA. J Nutr. 1996 Apr;126(4 Suppl):1165S-7S.
- Parfitt AM, Gallagher JC, Heaney RP, Johnston CC, Neer R, Whedon GD. Vitamin D and bone health in the elderly. Am J Clin Nutr. 1982 Nov;36(5 Suppl):1014-31.
30. McAlindon TE, Felson DT, Zhang Y, et al. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham study. Ann Int Med. 1996; 125:353-359.
- Lane NE, Gore L, Cummings SR, et al. Serum vitamin D levels and incident changes of radiographic osteoarthritis. Arthritis Rheum. 1999; 42:854-860.
31 Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet. 1997;349(9067):1715-1720.
32 Chamiec, T., Herbaczynska-Cedro, K., Ceremuzynski, L. Effects of antioxidant vitamin C and E on signal-averaged electrocardiogram in acute myocardial infarction Am. J. Cardiol.1996; 77, 4: 237-241
33 Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999;354(9177):447-455.
34 Eidelman RS, Hollar D, Hebert PR, Lamas GA, Hennekens CH. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med. 2004;164(14):1552-1556.
- Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 2003;361(9374):2017-2023.
- Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet. 2000;356(9237):1213-1218.
- Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342(3):154-160.
- Shekelle PG, Morton SC, Jungvig LK, et al. Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. J Gen Intern Med. 2004;19(4):380-389.
Collins R, Peto R, Armitage J. The MRC/BHF Heart Protection Study: preliminary results. Int J Clin Pract. 2002;56(1):53-56.
35 Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347(9004):781-786.
36 Steiner M. Vitamin E, a modifier of platelet function: rationale and use in cardiovascular disease. Nutr Rev. 1999; 57:306-309.
- Dowd P, Zheng ZB. On the mechanism of the anticlotting action of vitamin E quinone. Proc Natl Acad Sci USA. 1995; 92:8171-8175.
- Blackwell GJ, Radkomski M, Moncada S. Inhibition of human platelet aggregation by vitamin K. Throm Res. 1985; 37:103-114.
37 Rapola JM, Virtamo J, Ripatti S, et al. Effects of alpha-tocopherol and beta-carotene supplements on symptoms, progression, and prognosis of angina pectoris. Heart. 1998; 79:454-458.
38 Gey KF. Vitamins E plus C and interacting conutrients required for optimal health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer. Biofactors 1998;7(1-2):113-74.
- Khackik, F. et al. (1995) Lutein, lycopene and their oxidative metabolites in chemoprevention of cancer. Journal of Cellular Biochemistry, Supplement 22:236-246.
39 Giovannucci, E, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Annals of Internal Medicine, 1998;129:517-524.
- White, E. Relationship between vitamin and calcium supplement use and colon cancer. Cancer Epidemiology: Biomarkers and Prevention, 1997.
40 Bonn D. Vitamin E may reduce prostate-cancer incidence. Lancet 1998 Mar 28;351(9107):961.
41 Davies KM, Heaney RP, Recker RR, Lappe JM, Barger-Lux MJ, Rafferty K, Hinders S. Calcium intake and body weight. J Clin Endocrinol Metabol. 2000;85(12):4635-4638.
- Dietary Calcium Reduces Body Weight Heaney, R.P., Davies, K.M., Barger-Lux, M.J., "Calcium and Weight: Clinical Studies," Journal of the American College of Nutrition, 21(2), 2002, pages 152S-155S.
- Lin YC, Lyle RM, McCabe LD, McCabe GP, Weaver CM, Teegarden D. Dairy calcium is related to changes in body composition during a two-year exercise intervention in young women. J Am Coll Nutr. 2000;19(6):754-760.
42 Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications. Zemel MB. 2002. J Am Coll Nutr 21: 146S-151S.
- Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC. Regulation of adiposity by dietary calcium. FASEB J. 2000;14(9):1132-1138.
- Shi H et al. 2001. Effects of dietary calcium on adipocyte lipid metabolism and body weight regulation in energy-restricted aP2-agouti transgenic mice. FASEB J 5:291-293.
43 Heaney RP, Dowell SD, Bierman J, Hale CA, Bendich A. Absorbability and cost effectiveness in calcium supplementation. J Am Coll Nutr 2001;20:239-46.
44Kaats GR. et al. A randomized double blind placebo controlled study of the effects of chromium picolinate supplementation on body composition. Curr. Ther. Res. Clin. Exp. 1998; 59:379-388.
- Kaats GR. et al. Effects of chromium picolinate supplementation on body composition: A randomized double blind placebo controlled study. Curr. Ther. Res. 1996; 57:747-756.
45 Kinsman GD, Howard AN, Stone DL, Mullins PA. Studies in copper status and atherosclerosis. Biochem Soc Trans. 1990;18(6):1186-1188.
46 Klevay LM. Cardiovascular disease from copper deficiency--a history. J Nutr. 2000;130(2S Suppl):489S-492S.
47 Suharno D, West CE, Muhilal, Karyadi D, Hautvast JG. Supplementation with vitamin A and iron for nutritional anaemia in pregnant women in West Java, Indonesia. Lancet. 1993;342(8883):1325-1328.
48 Mauskop A, Altura BM. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci. 1998;5(1):24-27.
49 Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996;16(4):257-263.
- Pfaffenrath V, Wessely P, Meyer C, et al. Magnesium in the prophylaxis of migraine--a double-blind placebo-controlled study. Cephalalgia. 1996;16(6):436-440.
50 Shechter M, Merz CN, Paul-Labrador M, et al. Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease. Am J Cardiol. 1999;84(2):152-156.
- Shechter M, Sharir M, Labrador MJ, Forrester J, Silver B, Bairey Merz CN. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation. 2000;102(19):2353-2358.
51Das A, Jr., Hammad TA. Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthritis Cartilage. 2000;8(5):343-350.
52 Wuebbens MM, Liu MT, Rajagopalan K, Schindelin H. Insights into molybdenum cofactor deficiency provided by the crystal structure of the molybdenum cofactor biosynthesis protein MoaC. Structure Fold Des. 2000;8(7):709-718.
53 Remer T, Neubert A, Manz F. Increased risk of iodine deficiency with vegetarian nutrition. Br J Nutr. 1999;81(1):45-49.
- Davidsson L. Are vegetarians an 'at risk group' for iodine deficiency Br J Nutr. 1999;81(1):3-4.
54 Zimmerman MB and Kohrle J. The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid 2002;12:867-78.
55 Clark LC, Combs Jr GF, Turnbull BW, Slate EH, Chalker D, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL, Park HK, Sanders BB, Smith CL, Taylor JR. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. J Am Med Assoc 1996;276:1957-63.
56 Block, G. Vitamin C and cancer prevention, American Journal of Clinical Nutrition, 1991 supplement.
- Clark, L. C. et al. Effects of selenium supplementation for cancer prevention, Journal of the American Medical Association, 1996.
57 Oakley GP Jr. Eat right and take a multivitamin. N Engl J Med 1998 Apr 9;338(15):1060-1.
58. Sieve BF. The clinical effects of a new B complex factor, para-aminobenzoic acid, on pigmentation and fertility. South Med Surg. 1942;104:135–139.
59 Zarafonetis, CJ. Darkening of gray hair during para-amino-benzoic acid therapy. J Invest Dermatol. 1950 Dec;15(6):399-401.
- Zvak, C. The Science of Hair Care, 1986, Marcel Dekker, Inc., New York.
60. Brandaleone, H., Maine, E., and Steele, J.M. The effect of calcium panthothenate and para-aminobenzoic acid on gray hair in man. Am J Medical Science, 1944, 206: 315.
61. Kligman AM. Early destructive effect of sunlight on human skin. JAMA. 1969 Dec 29;210(13):2377-80.
62 Kligman LH, Akin FJ, Kligman AM. Sunscreens prevent ultraviolet photocarcinogenesis. J Am Acad Dermatol. 1980 Jul;3(1):30-5.
63 Synder DS, May M. Ability of PABA to protect mammalian skin from ultraviolet light-induced skin tumors and actinic damage. J Invest Dermatol. 1975 Dec;65(6):543-6.
64 Willis I, Kligman AM. Aminobenzoic acid and its esters. The quest for more effective sunscreens. Arch Dermatol. 1970 Oct;102(4):405-17.
65. Silver SM, Schroeder BM, Sterns RH. Brain uptake of myoinositol after exogenous administration. Department of Medicine, Rochester General Hospital, University of Rochester School of Medicine, Rochester, New York 14621, USA. J Am Soc Nephrol. 2002 May;13(5):1255-60.
66. Schmidt RE, Plurad SB, Coleman BD, Williamson JR, Tilton RG. Effects of sorbinil, dietary myo-inositol supplementation, and insulin on resolution of neuroaxonal dystrophy in mesenteric nerves of streptozocin-induced diabetic rats. Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110. Diabetes. 1991 May;40(5):574-82.
67. Gregersen G, Bertelsen B, Harbo H, Larsen E, Andersen JR, Helles A, Schmiegelow M, Christensen JE. Oral supplementation of myoinositol: effects on peripheral nerve function in human diabetics and on the concentration in plasma, erythrocytes, urine and muscle tissue in human diabetics and normals. Acta Neurol Scand. 1983 Mar;67(3):164-72.
68. Clements RS Jr, Vourganti B, Kuba T, Oh SJ, Darnell B. Dietary myo-inositol intake and peripheral nerve function in diabetic neuropathy. Metabolism. 1979 Apr;28(4 Suppl 1):477-83.
69. Salway JG, Whitehead L, Finnegan JA, Karunanayaka A, Barnett D, Payne RB. Effect of myo-inositol on peripheral-nerve function in diabetes. Lancet. 1978 Dec 16;2(8103):1282-4.
70. Khandelwal M, Reece EA, Wu YK, Borenstein M. Dietary myo-inositol therapy in hyperglycemia-induced embryopathy. Department of Obstetrics, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA. Teratology. 1998 Feb;57(2):79-84.
71. Reece EA, Khandelwal M, Wu YK, Borenstein M. Dietary intake of myo-inositol and neural tube defects in offspring of diabetic rats. Department of Obstetrics, Gynecology, and Reproductive Sciences, Temple University School of Medicine, Philadelphia, PA 19140, USA. Am J Obstet Gynecol. 1997 Mar;176(3):536-9.
72. Gelber D, Levine J, Belmaker RH. Effect of inositol on bulimia nervosa and binge eating. Ministry of Health Mental Health Center, Faculty of Health Sciences, Ben Gurion University of the Negev, P.O. Box 4600, Beersheva, Israel. Int J Eat Disord. 2001 Apr;29(3):345-8.
73. Levine J, Barak Y, Gonzalves M, Szor H, Elizur A, Kofman O, Belmaker RH. Double-blind, controlled trial of inositol treatment of depression. Yehuda Abarbanel Mental Health Center, Bat Yam, Israel. Am J Psychiatry. 1995 May;152(5):792-4.
- Levine J, Barak Y, Kofman O, Belmaker RH. Follow-up and relapse analysis of an inositol study of depression. Abarbanel Mental Health Center, Bat Yam, Israel. Isr J Psychiatry Relat Sci. 1995;32(1):14-21.
74. Chengappa KN, Levine J, Gershon S, Mallinger AG, Hardan A, Vagnucci A, Pollock B, Luther J, Buttenfield J, Verfaille S, Kupfer DJ. Inositol as an add-on treatment for bipolar depression. Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, PA, USA. Bipolar Disord. 2000 Mar;2(1):47-55.
75. Benjamin J, Agam G, Levine J, Bersudsky Y, Kofman O, Belmaker RH. Inositol treatment in psychiatry. Division of Psychiatry, Faculty of Health Sciences, Ben Gurion University of the Negev, Beersheva, Israel. Psychopharmacol Bull. 1995;31(1):167-75.
- Benjamin J, Agam G, Levine J, Bersudsky Y, Kofman O, Belmaker RH. Inositol treatment in psychiatry. Division of Psychiatry, Faculty of Health Sciences, Ben Gurion University of the Negev, Beersheva, Israel. Psychopharmacol Bull. 1995;31(1):167-75. Levine J. Controlled trials of inositol in psychiatry. Ministry of Health Mental Health Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beersheva, Israel. Eur Neuropsychopharmacol. 1997 May;7(2):147-55.
76. Wurtman RJ, Hefti F, Melamed E. Precursor control of neurotransmitter synthesis. Pharmacol Rev. 1981; 32:315-335.
77. Higgins JP, Flicker L. Lecithin for dementia and cognitive impairment. MRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge, Cambridgeshire, UK, CB2 2SR. Cochrane Database Syst Rev. 2000;(4):CD001015.
78. Whitehouse PJ. The cholinergic deficit in Alzheimer's disease. Department of Behavioral and Geriatric Neurology, Case Western Reserve University, University Alzheimer Center, Cleveland, Ohio 44120-5000, USA. J Clin Psychiatry. 1998;59 Suppl 13:19-22.
79. Canty DJ, Zeisel SH. Lecithin and choline in human health and disease. Nutr Rev. 1994; 52:327-339.
80. Harris CM, Dysken MW, Fovall P, Davis JM. Effect of lecithin on memory in normal adults. American Journal of Psychiatry. 1983;140(8):1010-1012.
81. Higgins JP, Flicker L. Lecithin for dementia and cognitive impairment. Cochrane Database System Review. 2000;(4):CD001015.
- "Brain-specific" nutrients: a memory cure McDaniel MA, Maier SF, Einstein GO. Nutrition. 2003 Nov-Dec;19(11-12):957-75.
82. Barbeau A. Emerging treatments: replacement therapy with choline or lecithin in neurological diseases. Canadian Journal of Neurological Sciences. 1978;5(1):157-160.
- Pomara N, Domino EF, Yoon H, Brinkman S, Tamminga CA, Gershon S. Failure of single-dose lecithin to alter aspects of central cholinergic activity in Alzheimer's disease. Journal of Clinical Psychiatry. 1983;44(8):293-295.
- Barbeau A. Lecithin in Parkinson's disease. Journal of Neural Transmission Supplement. 1980;(16):187-193.
Little A, Levy R, Chuaqui-Kidd P, Hand D. A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 1985;48(8):736-742.
- Perryman KM, Fitten LJ. Delayed matching-to-sample performance during a double-blind trial of tacrine (THA) and lecithin in patients with Alzheimer's disease. Life Science. 1993;53(6):479-486.
- Maltby N, Broe GA, Creasey H, Jorm AF, Christensen H, Brooks WS. Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double-blind trial. British Medical Journal 1994;308(6933):879-883.
83 Little A, Levy R, Chuaqui-Kidd P, Hand D. A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 1985;48(8):736-742.
- Perryman KM, Fitten LJ. Delayed matching-to-sample performance during a double-blind trial of tacrine (THA) and lecithin in patients with Alzheimer's disease. Life Science. 1993;53(6):479-486.
- Maltby N, Broe GA, Creasey H, Jorm AF, Christensen H, Brooks WS. Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double-blind trial. British Medical Journal 1994;308(6933):879-883.
84 Fitten LJ, Perryman KM, Gross PL, Fine H, Cummins J, Marshall C. Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study. American Journal of Psychiatry. 1990;147(2):239-242.
85 Brinkman SD, Smith RC, Meyer JS, et al. Lecithin and memory training in suspected Alzheimer's disease. Journal of Gerontology. 1982;37(1):4-9.
86 The effect of long-term high dose lecithin on erythrocyte choline transport in Alzheimer patients. Uney JB, Jones GM, Rebeiro A, Levy R Biol Psychiatry 1992 Mar 15 31:6 630-3
87 Simons LA, Hickie JB, Ruys J. Treatment of hypercholesterolaemia with oral lecithin. Australia and New Zealand Journal of Medicine. 1977;7(3):262-266.
88 Spilburg CA, Goldberg AC, McGill JB, et al. Fat-free foods supplemented with soy stanol-lecithin powder reduce cholesterol absorption and LDL cholesterol. Journal of the American Dietetic Association. 2003;103(5):577-581.
89 Buchman AL, Dubin M, Jenden D, et al. Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients. Gastroenterology. 1992;102(4 Pt 1):1363-1370.
90 Lecithin and choline in human health and disease. Canty DJ, Zeisel SH Nutr Rev 1994 Oct 52:10 327-39
- Blusztajn JK.Choline, a vital amine. Department of Pathology, Boston University School of Medicine, Boston, MA 02118, USA.Science. 1998 Aug 7;281(5378):794-5.
91 Hayashi H, Tanaka Y, Hibino H, Umeda Y, Kawamitsu H, Fujimoto H, Amakawa T. Beneficial effect of salmon roe phosphatidylcholine in chronic liver disease. Current Medical Research Opinion. 1999;15(3):177-184.

Parerea din pasajele acestui site nu a fost independent cercetate sau confirmate.